UCLE — US Nuclear Income Statement
0.000.00%
- $5.06m
- $5.75m
- $2.19m
- 28
- 13
- 56
- 22
Annual income statement for US Nuclear, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.75 | 2.14 | 2.09 | 2.23 | 2.19 |
| Cost of Revenue | |||||
| Gross Profit | 0.475 | 1.38 | 0.788 | 0.924 | 1.02 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.84 | 3.17 | 3.59 | 3.95 | 3.73 |
| Operating Profit | -2.08 | -1.03 | -1.5 | -1.72 | -1.54 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.54 | -1.88 | -2.04 | -3.43 | -1.74 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.54 | -1.88 | -2.04 | -3.43 | -1.74 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.54 | -1.88 | -2.04 | -3.43 | -1.74 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.54 | -1.93 | -2.06 | -3.44 | -1.81 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.16 | -0.083 | -0.07 | -0.093 | -0.039 |